重新定位药物用于与 podocyte 功能障碍相关的疾病
Stuart J Shankland1, J Ashley Jefferson2, Oliver Wessely3
1Division of Nephrology, University of Washington, Seattle, Washington, USA; Institute for Stem Cell & Regenerative Medicine, University of Washington, Seattle, Washington, USA.
重新利用现有的FDA批准的药物为治疗渐进的细胞疾病和慢性病提供了一个有希望的策略,有可能减少与新疗法相关的副作用和成本.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 足细胞疾病是渐进的,导致慢性病和功能衰竭.
- 目前的治疗包括非特异性免疫抑制剂,具有显著的副作用.
- 最近的进展揭示了受细胞损伤的分子机制.
结论:
- 重新使用已批准的药物是治疗 podocyte 疾病的可行策略.
- 解决当前非特异性免疫抑制疗法的局限性.
- 加快了慢性病新疗法的开发.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:06Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
Published on: July 2, 2020
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Prodrugs
Prodrugs help overcome...
Heart Failure Drugs: Diuretics
Drug Elimination by Renal Route: Tubular Secretion
EPS and iPS Cells in Disease Research
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
